nodes	percent_of_prediction	percent_of_DWPC	metapath
Dactinomycin—muscle cancer—urinary bladder cancer	0.197	0.36	CtDrD
Dactinomycin—testicular cancer—urinary bladder cancer	0.185	0.338	CtDrD
Dactinomycin—kidney cancer—urinary bladder cancer	0.165	0.302	CtDrD
Dactinomycin—ABCC6—Cisplatin—urinary bladder cancer	0.0644	0.182	CbGbCtD
Dactinomycin—ABCC6—Etoposide—urinary bladder cancer	0.0633	0.179	CbGbCtD
Dactinomycin—ABCC6—Doxorubicin—urinary bladder cancer	0.0432	0.122	CbGbCtD
Dactinomycin—ABCC1—Epirubicin—urinary bladder cancer	0.024	0.0677	CbGbCtD
Dactinomycin—ABCB1—Mitomycin—urinary bladder cancer	0.0219	0.062	CbGbCtD
Dactinomycin—ABCC1—Etoposide—urinary bladder cancer	0.0187	0.0528	CbGbCtD
Dactinomycin—ABCG2—Fluorouracil—urinary bladder cancer	0.015	0.0423	CbGbCtD
Dactinomycin—ABCG2—Carboplatin—urinary bladder cancer	0.0149	0.0421	CbGbCtD
Dactinomycin—ABCC1—Doxorubicin—urinary bladder cancer	0.0127	0.036	CbGbCtD
Dactinomycin—ABCG2—Cisplatin—urinary bladder cancer	0.0127	0.0359	CbGbCtD
Dactinomycin—ABCG2—Etoposide—urinary bladder cancer	0.0125	0.0353	CbGbCtD
Dactinomycin—ABCC1—Methotrexate—urinary bladder cancer	0.0123	0.0349	CbGbCtD
Dactinomycin—ABCG2—Doxorubicin—urinary bladder cancer	0.00852	0.0241	CbGbCtD
Dactinomycin—ABCG2—Methotrexate—urinary bladder cancer	0.00826	0.0233	CbGbCtD
Dactinomycin—ABCB1—Gemcitabine—urinary bladder cancer	0.00631	0.0178	CbGbCtD
Dactinomycin—ABCB1—Cisplatin—urinary bladder cancer	0.00459	0.013	CbGbCtD
Dactinomycin—ABCB1—Etoposide—urinary bladder cancer	0.00451	0.0127	CbGbCtD
Dactinomycin—ABCB1—Doxorubicin—urinary bladder cancer	0.00307	0.00868	CbGbCtD
Dactinomycin—ABCB1—Methotrexate—urinary bladder cancer	0.00298	0.00841	CbGbCtD
Dactinomycin—ABCC6—Podofilox—Etoposide—urinary bladder cancer	0.00168	1	CbGdCrCtD
Dactinomycin—ABCC6—renal system—urinary bladder cancer	0.000637	0.122	CbGeAlD
Dactinomycin—ABCC1—prostate gland—urinary bladder cancer	0.000375	0.0717	CbGeAlD
Dactinomycin—ABCB1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.000363	0.0803	CbGpPWpGaD
Dactinomycin—SLC22A5—prostate gland—urinary bladder cancer	0.00033	0.063	CbGeAlD
Dactinomycin—ABCC1—seminal vesicle—urinary bladder cancer	0.000317	0.0606	CbGeAlD
Dactinomycin—ABCC1—Synthesis of Leukotrienes (LT) and Eoxins (EX)—CYP4B1—urinary bladder cancer	0.000317	0.0702	CbGpPWpGaD
Dactinomycin—ABCG2—prostate gland—urinary bladder cancer	0.000311	0.0593	CbGeAlD
Dactinomycin—ABCC1—Cobalamin (Cbl, vitamin B12) transport and metabolism—PRSS3—urinary bladder cancer	0.000304	0.0672	CbGpPWpGaD
Dactinomycin—SLC22A5—seminal vesicle—urinary bladder cancer	0.000279	0.0533	CbGeAlD
Dactinomycin—ABCG2—seminal vesicle—urinary bladder cancer	0.000263	0.0502	CbGeAlD
Dactinomycin—ABCC1—urethra—urinary bladder cancer	0.000251	0.048	CbGeAlD
Dactinomycin—SLC22A5—renal system—urinary bladder cancer	0.000225	0.043	CbGeAlD
Dactinomycin—SLC22A5—urethra—urinary bladder cancer	0.000221	0.0422	CbGeAlD
Dactinomycin—ABCG2—urethra—urinary bladder cancer	0.000208	0.0397	CbGeAlD
Dactinomycin—ABCC1—vagina—urinary bladder cancer	0.000185	0.0354	CbGeAlD
Dactinomycin—SLC22A5—female reproductive system—urinary bladder cancer	0.00018	0.0344	CbGeAlD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—VHL—urinary bladder cancer	0.000167	0.0369	CbGpPWpGaD
Dactinomycin—SLC22A5—vagina—urinary bladder cancer	0.000163	0.0311	CbGeAlD
Dactinomycin—ABCC1—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.000159	0.0351	CbGpPWpGaD
Dactinomycin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.000157	0.0347	CbGpPWpGaD
Dactinomycin—ABCG2—vagina—urinary bladder cancer	0.000153	0.0293	CbGeAlD
Dactinomycin—ABCB1—prostate gland—urinary bladder cancer	0.000153	0.0293	CbGeAlD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—TYMP—urinary bladder cancer	0.000143	0.0317	CbGpPWpGaD
Dactinomycin—ABCB1—seminal vesicle—urinary bladder cancer	0.00013	0.0248	CbGeAlD
Dactinomycin—Leukopenia—Thiotepa—urinary bladder cancer	0.000129	0.00148	CcSEcCtD
Dactinomycin—Mouth ulceration—Methotrexate—urinary bladder cancer	0.000129	0.00147	CcSEcCtD
Dactinomycin—Chills—Gemcitabine—urinary bladder cancer	0.000125	0.00143	CcSEcCtD
Dactinomycin—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.000125	0.00143	CcSEcCtD
Dactinomycin—Agranulocytosis—Etoposide—urinary bladder cancer	0.000124	0.00141	CcSEcCtD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO2—urinary bladder cancer	0.000124	0.0274	CbGpPWpGaD
Dactinomycin—Sepsis—Methotrexate—urinary bladder cancer	0.000123	0.00141	CcSEcCtD
Dactinomycin—Alopecia—Gemcitabine—urinary bladder cancer	0.000123	0.00141	CcSEcCtD
Dactinomycin—Myalgia—Thiotepa—urinary bladder cancer	0.000123	0.0014	CcSEcCtD
Dactinomycin—Oesophagitis—Epirubicin—urinary bladder cancer	0.000122	0.00139	CcSEcCtD
Dactinomycin—Erythema—Gemcitabine—urinary bladder cancer	0.000121	0.00139	CcSEcCtD
Dactinomycin—Alopecia—Fluorouracil—urinary bladder cancer	0.000121	0.00138	CcSEcCtD
Dactinomycin—Flushing—Cisplatin—urinary bladder cancer	0.000121	0.00138	CcSEcCtD
Dactinomycin—Mouth ulceration—Epirubicin—urinary bladder cancer	0.00012	0.00137	CcSEcCtD
Dactinomycin—ABCC1—lymph node—urinary bladder cancer	0.00012	0.0229	CbGeAlD
Dactinomycin—Erythema—Fluorouracil—urinary bladder cancer	0.000119	0.00136	CcSEcCtD
Dactinomycin—Infection—Thiotepa—urinary bladder cancer	0.000117	0.00134	CcSEcCtD
Dactinomycin—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.000116	0.00132	CcSEcCtD
Dactinomycin—Sepsis—Epirubicin—urinary bladder cancer	0.000115	0.00132	CcSEcCtD
Dactinomycin—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000115	0.00132	CcSEcCtD
Dactinomycin—Alopecia—Cisplatin—urinary bladder cancer	0.000115	0.00131	CcSEcCtD
Dactinomycin—Hepatic failure—Methotrexate—urinary bladder cancer	0.000115	0.00131	CcSEcCtD
Dactinomycin—Erythema—Cisplatin—urinary bladder cancer	0.000113	0.00129	CcSEcCtD
Dactinomycin—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000113	0.00129	CcSEcCtD
Dactinomycin—Erythema multiforme—Etoposide—urinary bladder cancer	0.000113	0.00129	CcSEcCtD
Dactinomycin—ABCB1—epithelium—urinary bladder cancer	0.000113	0.0215	CbGeAlD
Dactinomycin—Oesophagitis—Doxorubicin—urinary bladder cancer	0.000112	0.00128	CcSEcCtD
Dactinomycin—Anorexia—Thiotepa—urinary bladder cancer	0.000112	0.00128	CcSEcCtD
Dactinomycin—Anaemia—Gemcitabine—urinary bladder cancer	0.000112	0.00128	CcSEcCtD
Dactinomycin—Phlebitis—Epirubicin—urinary bladder cancer	0.000112	0.00128	CcSEcCtD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—RRM2—urinary bladder cancer	0.000112	0.0247	CbGpPWpGaD
Dactinomycin—Mouth ulceration—Doxorubicin—urinary bladder cancer	0.000111	0.00127	CcSEcCtD
Dactinomycin—Flushing—Etoposide—urinary bladder cancer	0.000111	0.00126	CcSEcCtD
Dactinomycin—Anaemia—Fluorouracil—urinary bladder cancer	0.00011	0.00126	CcSEcCtD
Dactinomycin—Malaise—Gemcitabine—urinary bladder cancer	0.00011	0.00125	CcSEcCtD
Dactinomycin—Leukopenia—Gemcitabine—urinary bladder cancer	0.000109	0.00124	CcSEcCtD
Dactinomycin—Hepatic failure—Epirubicin—urinary bladder cancer	0.000107	0.00123	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000107	0.00123	CcSEcCtD
Dactinomycin—Chills—Etoposide—urinary bladder cancer	0.000107	0.00122	CcSEcCtD
Dactinomycin—Leukopenia—Fluorouracil—urinary bladder cancer	0.000107	0.00122	CcSEcCtD
Dactinomycin—Sepsis—Doxorubicin—urinary bladder cancer	0.000107	0.00122	CcSEcCtD
Dactinomycin—SLC22A5—lymph node—urinary bladder cancer	0.000105	0.0201	CbGeAlD
Dactinomycin—Alopecia—Etoposide—urinary bladder cancer	0.000105	0.0012	CcSEcCtD
Dactinomycin—Lethargy—Methotrexate—urinary bladder cancer	0.000105	0.0012	CcSEcCtD
Dactinomycin—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000105	0.0012	CcSEcCtD
Dactinomycin—Anaemia—Cisplatin—urinary bladder cancer	0.000105	0.0012	CcSEcCtD
Dactinomycin—ABCB1—renal system—urinary bladder cancer	0.000104	0.0199	CbGeAlD
Dactinomycin—Phlebitis—Doxorubicin—urinary bladder cancer	0.000104	0.00118	CcSEcCtD
Dactinomycin—Myalgia—Gemcitabine—urinary bladder cancer	0.000103	0.00118	CcSEcCtD
Dactinomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000103	0.0227	CbGpPWpGaD
Dactinomycin—ABCB1—urethra—urinary bladder cancer	0.000103	0.0196	CbGeAlD
Dactinomycin—Decreased appetite—Thiotepa—urinary bladder cancer	0.000102	0.00117	CcSEcCtD
Dactinomycin—Discomfort—Gemcitabine—urinary bladder cancer	0.000102	0.00117	CcSEcCtD
Dactinomycin—Malaise—Cisplatin—urinary bladder cancer	0.000102	0.00117	CcSEcCtD
Dactinomycin—Myalgia—Fluorouracil—urinary bladder cancer	0.000102	0.00116	CcSEcCtD
Dactinomycin—Fatigue—Thiotepa—urinary bladder cancer	0.000102	0.00116	CcSEcCtD
Dactinomycin—Leukopenia—Cisplatin—urinary bladder cancer	0.000101	0.00116	CcSEcCtD
Dactinomycin—Pain—Thiotepa—urinary bladder cancer	0.000101	0.00115	CcSEcCtD
Dactinomycin—Discomfort—Fluorouracil—urinary bladder cancer	0.0001	0.00115	CcSEcCtD
Dactinomycin—Hepatic failure—Doxorubicin—urinary bladder cancer	9.94e-05	0.00114	CcSEcCtD
Dactinomycin—ABCG2—lymph node—urinary bladder cancer	9.92e-05	0.019	CbGeAlD
Dactinomycin—Oedema—Gemcitabine—urinary bladder cancer	9.92e-05	0.00113	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	9.86e-05	0.0218	CbGpPWpGaD
Dactinomycin—Lethargy—Epirubicin—urinary bladder cancer	9.85e-05	0.00113	CcSEcCtD
Dactinomycin—Infection—Gemcitabine—urinary bladder cancer	9.85e-05	0.00113	CcSEcCtD
Dactinomycin—Oedema—Fluorouracil—urinary bladder cancer	9.75e-05	0.00111	CcSEcCtD
Dactinomycin—Feeling abnormal—Thiotepa—urinary bladder cancer	9.71e-05	0.00111	CcSEcCtD
Dactinomycin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	9.71e-05	0.00111	CcSEcCtD
Dactinomycin—Infection—Fluorouracil—urinary bladder cancer	9.69e-05	0.00111	CcSEcCtD
Dactinomycin—Myalgia—Cisplatin—urinary bladder cancer	9.64e-05	0.0011	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	9.64e-05	0.0011	CcSEcCtD
Dactinomycin—Ill-defined disorder—Etoposide—urinary bladder cancer	9.63e-05	0.0011	CcSEcCtD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—urinary bladder cancer	9.61e-05	0.0213	CbGpPWpGaD
Dactinomycin—Anaemia—Etoposide—urinary bladder cancer	9.59e-05	0.0011	CcSEcCtD
Dactinomycin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	9.55e-05	0.00109	CcSEcCtD
Dactinomycin—Liver function test abnormal—Methotrexate—urinary bladder cancer	9.53e-05	0.00109	CcSEcCtD
Dactinomycin—Discomfort—Cisplatin—urinary bladder cancer	9.53e-05	0.00109	CcSEcCtD
Dactinomycin—Anorexia—Gemcitabine—urinary bladder cancer	9.45e-05	0.00108	CcSEcCtD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—urinary bladder cancer	9.37e-05	0.0207	CbGpPWpGaD
Dactinomycin—Malaise—Etoposide—urinary bladder cancer	9.36e-05	0.00107	CcSEcCtD
Dactinomycin—Body temperature increased—Thiotepa—urinary bladder cancer	9.32e-05	0.00106	CcSEcCtD
Dactinomycin—Abdominal pain—Thiotepa—urinary bladder cancer	9.32e-05	0.00106	CcSEcCtD
Dactinomycin—Anorexia—Fluorouracil—urinary bladder cancer	9.29e-05	0.00106	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	9.29e-05	0.00106	CcSEcCtD
Dactinomycin—Leukopenia—Etoposide—urinary bladder cancer	9.29e-05	0.00106	CcSEcCtD
Dactinomycin—Oedema—Cisplatin—urinary bladder cancer	9.24e-05	0.00106	CcSEcCtD
Dactinomycin—Infection—Cisplatin—urinary bladder cancer	9.18e-05	0.00105	CcSEcCtD
Dactinomycin—Lethargy—Doxorubicin—urinary bladder cancer	9.12e-05	0.00104	CcSEcCtD
Dactinomycin—Thrombocytopenia—Cisplatin—urinary bladder cancer	9.05e-05	0.00103	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	9.03e-05	0.00103	CcSEcCtD
Dactinomycin—Liver function test abnormal—Epirubicin—urinary bladder cancer	8.92e-05	0.00102	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	8.88e-05	0.00101	CcSEcCtD
Dactinomycin—Anorexia—Cisplatin—urinary bladder cancer	8.81e-05	0.00101	CcSEcCtD
Dactinomycin—Discomfort—Etoposide—urinary bladder cancer	8.73e-05	0.000997	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	8.7e-05	0.000993	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	8.7e-05	0.000993	CcSEcCtD
Dactinomycin—Hypersensitivity—Thiotepa—urinary bladder cancer	8.68e-05	0.000992	CcSEcCtD
Dactinomycin—Decreased appetite—Gemcitabine—urinary bladder cancer	8.62e-05	0.000984	CcSEcCtD
Dactinomycin—Fatigue—Gemcitabine—urinary bladder cancer	8.55e-05	0.000976	CcSEcCtD
Dactinomycin—Pain—Gemcitabine—urinary bladder cancer	8.48e-05	0.000968	CcSEcCtD
Dactinomycin—Decreased appetite—Fluorouracil—urinary bladder cancer	8.48e-05	0.000968	CcSEcCtD
Dactinomycin—Pancytopenia—Methotrexate—urinary bladder cancer	8.47e-05	0.000967	CcSEcCtD
Dactinomycin—Asthenia—Thiotepa—urinary bladder cancer	8.46e-05	0.000966	CcSEcCtD
Dactinomycin—ABCC1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	8.43e-05	0.0187	CbGpPWpGaD
Dactinomycin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	8.42e-05	0.000962	CcSEcCtD
Dactinomycin—Infection—Etoposide—urinary bladder cancer	8.41e-05	0.000961	CcSEcCtD
Dactinomycin—ABCB1—female reproductive system—urinary bladder cancer	8.36e-05	0.016	CbGeAlD
Dactinomycin—Dysphagia—Epirubicin—urinary bladder cancer	8.35e-05	0.000953	CcSEcCtD
Dactinomycin—Neutropenia—Methotrexate—urinary bladder cancer	8.34e-05	0.000952	CcSEcCtD
Dactinomycin—Pain—Fluorouracil—urinary bladder cancer	8.34e-05	0.000952	CcSEcCtD
Dactinomycin—Thrombocytopenia—Etoposide—urinary bladder cancer	8.29e-05	0.000947	CcSEcCtD
Dactinomycin—Liver function test abnormal—Doxorubicin—urinary bladder cancer	8.25e-05	0.000942	CcSEcCtD
Dactinomycin—Feeling abnormal—Gemcitabine—urinary bladder cancer	8.17e-05	0.000933	CcSEcCtD
Dactinomycin—Anorexia—Etoposide—urinary bladder cancer	8.07e-05	0.000922	CcSEcCtD
Dactinomycin—Diarrhoea—Thiotepa—urinary bladder cancer	8.07e-05	0.000921	CcSEcCtD
Dactinomycin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	8.05e-05	0.000919	CcSEcCtD
Dactinomycin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	8.05e-05	0.000919	CcSEcCtD
Dactinomycin—Decreased appetite—Cisplatin—urinary bladder cancer	8.03e-05	0.000918	CcSEcCtD
Dactinomycin—Feeling abnormal—Fluorouracil—urinary bladder cancer	8.03e-05	0.000918	CcSEcCtD
Dactinomycin—Pneumonia—Methotrexate—urinary bladder cancer	8e-05	0.000913	CcSEcCtD
Dactinomycin—Pancytopenia—Epirubicin—urinary bladder cancer	7.93e-05	0.000905	CcSEcCtD
Dactinomycin—Pain—Cisplatin—urinary bladder cancer	7.9e-05	0.000903	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	7.88e-05	0.0009	CcSEcCtD
Dactinomycin—Body temperature increased—Gemcitabine—urinary bladder cancer	7.84e-05	0.000895	CcSEcCtD
Dactinomycin—Neutropenia—Epirubicin—urinary bladder cancer	7.8e-05	0.000891	CcSEcCtD
Dactinomycin—Stomatitis—Methotrexate—urinary bladder cancer	7.75e-05	0.000885	CcSEcCtD
Dactinomycin—Dysphagia—Doxorubicin—urinary bladder cancer	7.72e-05	0.000882	CcSEcCtD
Dactinomycin—Body temperature increased—Fluorouracil—urinary bladder cancer	7.71e-05	0.00088	CcSEcCtD
Dactinomycin—Feeling abnormal—Cisplatin—urinary bladder cancer	7.62e-05	0.00087	CcSEcCtD
Dactinomycin—ABCG2—Iron uptake and transport—TFRC—urinary bladder cancer	7.61e-05	0.0168	CbGpPWpGaD
Dactinomycin—ABCB1—vagina—urinary bladder cancer	7.56e-05	0.0144	CbGeAlD
Dactinomycin—Vomiting—Thiotepa—urinary bladder cancer	7.49e-05	0.000856	CcSEcCtD
Dactinomycin—Pneumonia—Epirubicin—urinary bladder cancer	7.49e-05	0.000855	CcSEcCtD
Dactinomycin—Rash—Thiotepa—urinary bladder cancer	7.43e-05	0.000849	CcSEcCtD
Dactinomycin—Agranulocytosis—Methotrexate—urinary bladder cancer	7.42e-05	0.000848	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	7.38e-05	0.000843	CcSEcCtD
Dactinomycin—Decreased appetite—Etoposide—urinary bladder cancer	7.36e-05	0.000841	CcSEcCtD
Dactinomycin—Pancytopenia—Doxorubicin—urinary bladder cancer	7.33e-05	0.000838	CcSEcCtD
Dactinomycin—Body temperature increased—Cisplatin—urinary bladder cancer	7.31e-05	0.000834	CcSEcCtD
Dactinomycin—Fatigue—Etoposide—urinary bladder cancer	7.3e-05	0.000834	CcSEcCtD
Dactinomycin—Stomatitis—Epirubicin—urinary bladder cancer	7.25e-05	0.000828	CcSEcCtD
Dactinomycin—Pain—Etoposide—urinary bladder cancer	7.24e-05	0.000827	CcSEcCtD
Dactinomycin—Neutropenia—Doxorubicin—urinary bladder cancer	7.22e-05	0.000825	CcSEcCtD
Dactinomycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	7.18e-05	0.00082	CcSEcCtD
Dactinomycin—Hepatitis—Methotrexate—urinary bladder cancer	7.14e-05	0.000815	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.13e-05	0.0158	CbGpPWpGaD
Dactinomycin—SLC22A5—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	7.12e-05	0.0158	CbGpPWpGaD
Dactinomycin—Asthenia—Gemcitabine—urinary bladder cancer	7.11e-05	0.000813	CcSEcCtD
Dactinomycin—Pharyngitis—Methotrexate—urinary bladder cancer	7.09e-05	0.000809	CcSEcCtD
Dactinomycin—ABCC1—S1P1 pathway—RHOA—urinary bladder cancer	7.04e-05	0.0156	CbGpPWpGaD
Dactinomycin—Nausea—Thiotepa—urinary bladder cancer	7e-05	0.0008	CcSEcCtD
Dactinomycin—Feeling abnormal—Etoposide—urinary bladder cancer	6.98e-05	0.000797	CcSEcCtD
Dactinomycin—Agranulocytosis—Epirubicin—urinary bladder cancer	6.94e-05	0.000793	CcSEcCtD
Dactinomycin—Pneumonia—Doxorubicin—urinary bladder cancer	6.93e-05	0.000791	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Etoposide—urinary bladder cancer	6.92e-05	0.000791	CcSEcCtD
Dactinomycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	6.83e-05	0.00078	CcSEcCtD
Dactinomycin—Hypersensitivity—Cisplatin—urinary bladder cancer	6.81e-05	0.000778	CcSEcCtD
Dactinomycin—Diarrhoea—Gemcitabine—urinary bladder cancer	6.78e-05	0.000775	CcSEcCtD
Dactinomycin—Erythema multiforme—Methotrexate—urinary bladder cancer	6.75e-05	0.000771	CcSEcCtD
Dactinomycin—Stomatitis—Doxorubicin—urinary bladder cancer	6.71e-05	0.000767	CcSEcCtD
Dactinomycin—Abdominal pain—Etoposide—urinary bladder cancer	6.69e-05	0.000764	CcSEcCtD
Dactinomycin—Body temperature increased—Etoposide—urinary bladder cancer	6.69e-05	0.000764	CcSEcCtD
Dactinomycin—Hepatitis—Epirubicin—urinary bladder cancer	6.68e-05	0.000763	CcSEcCtD
Dactinomycin—Diarrhoea—Fluorouracil—urinary bladder cancer	6.67e-05	0.000762	CcSEcCtD
Dactinomycin—Asthenia—Cisplatin—urinary bladder cancer	6.63e-05	0.000757	CcSEcCtD
Dactinomycin—Pharyngitis—Epirubicin—urinary bladder cancer	6.63e-05	0.000757	CcSEcCtD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	6.47e-05	0.0143	CbGpPWpGaD
Dactinomycin—Agranulocytosis—Doxorubicin—urinary bladder cancer	6.43e-05	0.000734	CcSEcCtD
Dactinomycin—Chills—Methotrexate—urinary bladder cancer	6.41e-05	0.000732	CcSEcCtD
Dactinomycin—ABCC1—S1P1 pathway—PTGS2—urinary bladder cancer	6.37e-05	0.0141	CbGpPWpGaD
Dactinomycin—Diarrhoea—Cisplatin—urinary bladder cancer	6.32e-05	0.000722	CcSEcCtD
Dactinomycin—Erythema multiforme—Epirubicin—urinary bladder cancer	6.32e-05	0.000721	CcSEcCtD
Dactinomycin—Alopecia—Methotrexate—urinary bladder cancer	6.31e-05	0.00072	CcSEcCtD
Dactinomycin—Vomiting—Gemcitabine—urinary bladder cancer	6.3e-05	0.00072	CcSEcCtD
Dactinomycin—Rash—Gemcitabine—urinary bladder cancer	6.25e-05	0.000714	CcSEcCtD
Dactinomycin—Hypersensitivity—Etoposide—urinary bladder cancer	6.24e-05	0.000712	CcSEcCtD
Dactinomycin—Erythema—Methotrexate—urinary bladder cancer	6.21e-05	0.00071	CcSEcCtD
Dactinomycin—Flushing—Epirubicin—urinary bladder cancer	6.2e-05	0.000708	CcSEcCtD
Dactinomycin—Vomiting—Fluorouracil—urinary bladder cancer	6.2e-05	0.000708	CcSEcCtD
Dactinomycin—Hepatitis—Doxorubicin—urinary bladder cancer	6.18e-05	0.000706	CcSEcCtD
Dactinomycin—Rash—Fluorouracil—urinary bladder cancer	6.15e-05	0.000702	CcSEcCtD
Dactinomycin—Pharyngitis—Doxorubicin—urinary bladder cancer	6.14e-05	0.000701	CcSEcCtD
Dactinomycin—Asthenia—Etoposide—urinary bladder cancer	6.08e-05	0.000694	CcSEcCtD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	6.01e-05	0.0133	CbGpPWpGaD
Dactinomycin—Chills—Epirubicin—urinary bladder cancer	5.99e-05	0.000685	CcSEcCtD
Dactinomycin—Alopecia—Epirubicin—urinary bladder cancer	5.9e-05	0.000674	CcSEcCtD
Dactinomycin—Nausea—Gemcitabine—urinary bladder cancer	5.89e-05	0.000673	CcSEcCtD
Dactinomycin—Vomiting—Cisplatin—urinary bladder cancer	5.88e-05	0.000671	CcSEcCtD
Dactinomycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	5.84e-05	0.000667	CcSEcCtD
Dactinomycin—Rash—Cisplatin—urinary bladder cancer	5.83e-05	0.000666	CcSEcCtD
Dactinomycin—Erythema—Epirubicin—urinary bladder cancer	5.82e-05	0.000664	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.81e-05	0.0129	CbGpPWpGaD
Dactinomycin—Diarrhoea—Etoposide—urinary bladder cancer	5.79e-05	0.000662	CcSEcCtD
Dactinomycin—Nausea—Fluorouracil—urinary bladder cancer	5.79e-05	0.000661	CcSEcCtD
Dactinomycin—Ill-defined disorder—Methotrexate—urinary bladder cancer	5.77e-05	0.000659	CcSEcCtD
Dactinomycin—Anaemia—Methotrexate—urinary bladder cancer	5.74e-05	0.000656	CcSEcCtD
Dactinomycin—Flushing—Doxorubicin—urinary bladder cancer	5.74e-05	0.000655	CcSEcCtD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	5.65e-05	0.0125	CbGpPWpGaD
Dactinomycin—Malaise—Methotrexate—urinary bladder cancer	5.6e-05	0.00064	CcSEcCtD
Dactinomycin—Leukopenia—Methotrexate—urinary bladder cancer	5.56e-05	0.000635	CcSEcCtD
Dactinomycin—Chills—Doxorubicin—urinary bladder cancer	5.55e-05	0.000633	CcSEcCtD
Dactinomycin—Nausea—Cisplatin—urinary bladder cancer	5.49e-05	0.000627	CcSEcCtD
Dactinomycin—Alopecia—Doxorubicin—urinary bladder cancer	5.46e-05	0.000624	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	5.4e-05	0.012	CbGpPWpGaD
Dactinomycin—Ill-defined disorder—Epirubicin—urinary bladder cancer	5.4e-05	0.000616	CcSEcCtD
Dactinomycin—Vomiting—Etoposide—urinary bladder cancer	5.38e-05	0.000615	CcSEcCtD
Dactinomycin—Erythema—Doxorubicin—urinary bladder cancer	5.38e-05	0.000615	CcSEcCtD
Dactinomycin—Anaemia—Epirubicin—urinary bladder cancer	5.38e-05	0.000614	CcSEcCtD
Dactinomycin—Rash—Etoposide—urinary bladder cancer	5.34e-05	0.00061	CcSEcCtD
Dactinomycin—Myalgia—Methotrexate—urinary bladder cancer	5.29e-05	0.000604	CcSEcCtD
Dactinomycin—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	5.26e-05	0.0117	CbGpPWpGaD
Dactinomycin—Malaise—Epirubicin—urinary bladder cancer	5.24e-05	0.000599	CcSEcCtD
Dactinomycin—Discomfort—Methotrexate—urinary bladder cancer	5.23e-05	0.000597	CcSEcCtD
Dactinomycin—Leukopenia—Epirubicin—urinary bladder cancer	5.21e-05	0.000595	CcSEcCtD
Dactinomycin—Infection—Methotrexate—urinary bladder cancer	5.04e-05	0.000575	CcSEcCtD
Dactinomycin—Nausea—Etoposide—urinary bladder cancer	5.03e-05	0.000574	CcSEcCtD
Dactinomycin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.99e-05	0.00057	CcSEcCtD
Dactinomycin—ABCC1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	4.99e-05	0.011	CbGpPWpGaD
Dactinomycin—Anaemia—Doxorubicin—urinary bladder cancer	4.97e-05	0.000568	CcSEcCtD
Dactinomycin—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.97e-05	0.000567	CcSEcCtD
Dactinomycin—Myalgia—Epirubicin—urinary bladder cancer	4.95e-05	0.000565	CcSEcCtD
Dactinomycin—Discomfort—Epirubicin—urinary bladder cancer	4.89e-05	0.000559	CcSEcCtD
Dactinomycin—ABCB1—lymph node—urinary bladder cancer	4.89e-05	0.00935	CbGeAlD
Dactinomycin—Malaise—Doxorubicin—urinary bladder cancer	4.85e-05	0.000554	CcSEcCtD
Dactinomycin—Anorexia—Methotrexate—urinary bladder cancer	4.83e-05	0.000552	CcSEcCtD
Dactinomycin—Leukopenia—Doxorubicin—urinary bladder cancer	4.82e-05	0.00055	CcSEcCtD
Dactinomycin—Oedema—Epirubicin—urinary bladder cancer	4.75e-05	0.000542	CcSEcCtD
Dactinomycin—Infection—Epirubicin—urinary bladder cancer	4.72e-05	0.000539	CcSEcCtD
Dactinomycin—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.65e-05	0.000531	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	4.62e-05	0.000528	CcSEcCtD
Dactinomycin—Myalgia—Doxorubicin—urinary bladder cancer	4.58e-05	0.000523	CcSEcCtD
Dactinomycin—Discomfort—Doxorubicin—urinary bladder cancer	4.53e-05	0.000517	CcSEcCtD
Dactinomycin—Anorexia—Epirubicin—urinary bladder cancer	4.52e-05	0.000517	CcSEcCtD
Dactinomycin—Decreased appetite—Methotrexate—urinary bladder cancer	4.41e-05	0.000504	CcSEcCtD
Dactinomycin—Oedema—Doxorubicin—urinary bladder cancer	4.39e-05	0.000502	CcSEcCtD
Dactinomycin—Fatigue—Methotrexate—urinary bladder cancer	4.37e-05	0.000499	CcSEcCtD
Dactinomycin—Infection—Doxorubicin—urinary bladder cancer	4.36e-05	0.000498	CcSEcCtD
Dactinomycin—Pain—Methotrexate—urinary bladder cancer	4.34e-05	0.000495	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	4.32e-05	0.000494	CcSEcCtD
Dactinomycin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	4.3e-05	0.000491	CcSEcCtD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—CREBBP—urinary bladder cancer	4.3e-05	0.00951	CbGpPWpGaD
Dactinomycin—Anorexia—Doxorubicin—urinary bladder cancer	4.19e-05	0.000478	CcSEcCtD
Dactinomycin—Feeling abnormal—Methotrexate—urinary bladder cancer	4.18e-05	0.000477	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	4.15e-05	0.000474	CcSEcCtD
Dactinomycin—Decreased appetite—Epirubicin—urinary bladder cancer	4.13e-05	0.000471	CcSEcCtD
Dactinomycin—Fatigue—Epirubicin—urinary bladder cancer	4.09e-05	0.000467	CcSEcCtD
Dactinomycin—Pain—Epirubicin—urinary bladder cancer	4.06e-05	0.000464	CcSEcCtD
Dactinomycin—Abdominal pain—Methotrexate—urinary bladder cancer	4.01e-05	0.000458	CcSEcCtD
Dactinomycin—Body temperature increased—Methotrexate—urinary bladder cancer	4.01e-05	0.000458	CcSEcCtD
Dactinomycin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	4e-05	0.000457	CcSEcCtD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.93e-05	0.00869	CbGpPWpGaD
Dactinomycin—Feeling abnormal—Epirubicin—urinary bladder cancer	3.91e-05	0.000447	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.88e-05	0.000443	CcSEcCtD
Dactinomycin—Decreased appetite—Doxorubicin—urinary bladder cancer	3.82e-05	0.000436	CcSEcCtD
Dactinomycin—Fatigue—Doxorubicin—urinary bladder cancer	3.79e-05	0.000432	CcSEcCtD
Dactinomycin—Pain—Doxorubicin—urinary bladder cancer	3.76e-05	0.000429	CcSEcCtD
Dactinomycin—Abdominal pain—Epirubicin—urinary bladder cancer	3.75e-05	0.000429	CcSEcCtD
Dactinomycin—Body temperature increased—Epirubicin—urinary bladder cancer	3.75e-05	0.000429	CcSEcCtD
Dactinomycin—Hypersensitivity—Methotrexate—urinary bladder cancer	3.74e-05	0.000427	CcSEcCtD
Dactinomycin—Asthenia—Methotrexate—urinary bladder cancer	3.64e-05	0.000416	CcSEcCtD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	3.62e-05	0.00801	CbGpPWpGaD
Dactinomycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.62e-05	0.000413	CcSEcCtD
Dactinomycin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.59e-05	0.00041	CcSEcCtD
Dactinomycin—Hypersensitivity—Epirubicin—urinary bladder cancer	3.5e-05	0.000399	CcSEcCtD
Dactinomycin—Abdominal pain—Doxorubicin—urinary bladder cancer	3.47e-05	0.000396	CcSEcCtD
Dactinomycin—Body temperature increased—Doxorubicin—urinary bladder cancer	3.47e-05	0.000396	CcSEcCtD
Dactinomycin—Diarrhoea—Methotrexate—urinary bladder cancer	3.47e-05	0.000396	CcSEcCtD
Dactinomycin—Asthenia—Epirubicin—urinary bladder cancer	3.41e-05	0.000389	CcSEcCtD
Dactinomycin—Diarrhoea—Epirubicin—urinary bladder cancer	3.25e-05	0.000371	CcSEcCtD
Dactinomycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	3.24e-05	0.00037	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	3.24e-05	0.00716	CbGpPWpGaD
Dactinomycin—Vomiting—Methotrexate—urinary bladder cancer	3.22e-05	0.000368	CcSEcCtD
Dactinomycin—Rash—Methotrexate—urinary bladder cancer	3.2e-05	0.000365	CcSEcCtD
Dactinomycin—Asthenia—Doxorubicin—urinary bladder cancer	3.15e-05	0.00036	CcSEcCtD
Dactinomycin—Vomiting—Epirubicin—urinary bladder cancer	3.02e-05	0.000345	CcSEcCtD
Dactinomycin—Nausea—Methotrexate—urinary bladder cancer	3.01e-05	0.000344	CcSEcCtD
Dactinomycin—Diarrhoea—Doxorubicin—urinary bladder cancer	3e-05	0.000343	CcSEcCtD
Dactinomycin—Rash—Epirubicin—urinary bladder cancer	2.99e-05	0.000342	CcSEcCtD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—urinary bladder cancer	2.96e-05	0.00654	CbGpPWpGaD
Dactinomycin—ABCC1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	2.94e-05	0.0065	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-2-alpha transcription factor network—EP300—urinary bladder cancer	2.93e-05	0.00648	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	2.92e-05	0.00646	CbGpPWpGaD
Dactinomycin—Nausea—Epirubicin—urinary bladder cancer	2.82e-05	0.000322	CcSEcCtD
Dactinomycin—Vomiting—Doxorubicin—urinary bladder cancer	2.79e-05	0.000319	CcSEcCtD
Dactinomycin—Rash—Doxorubicin—urinary bladder cancer	2.77e-05	0.000316	CcSEcCtD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	2.62e-05	0.00579	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.62e-05	0.00579	CbGpPWpGaD
Dactinomycin—Nausea—Doxorubicin—urinary bladder cancer	2.61e-05	0.000298	CcSEcCtD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	2.53e-05	0.00559	CbGpPWpGaD
Dactinomycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	2.42e-05	0.00535	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.3e-05	0.0051	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	2.27e-05	0.00501	CbGpPWpGaD
Dactinomycin—ABCG2—Fluoropyrimidine Activity—TP53—urinary bladder cancer	2.14e-05	0.00475	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	2.13e-05	0.00472	CbGpPWpGaD
Dactinomycin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	1.9e-05	0.00421	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.89e-05	0.00419	CbGpPWpGaD
Dactinomycin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	1.89e-05	0.00417	CbGpPWpGaD
Dactinomycin—ABCC6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.84e-05	0.00407	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	1.8e-05	0.00398	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	1.75e-05	0.00387	CbGpPWpGaD
Dactinomycin—ABCG2—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	1.72e-05	0.00381	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.66e-05	0.00368	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.54e-05	0.00341	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	1.54e-05	0.00341	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—GSTO2—urinary bladder cancer	1.46e-05	0.00324	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.44e-05	0.00319	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	1.37e-05	0.00304	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	1.37e-05	0.00302	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	1.36e-05	0.00302	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.36e-05	0.003	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTZ1—urinary bladder cancer	1.29e-05	0.00286	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	1.24e-05	0.00275	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NAT1—urinary bladder cancer	1.23e-05	0.00271	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTO2—urinary bladder cancer	1.23e-05	0.00271	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.21e-05	0.00267	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SLC19A1—urinary bladder cancer	1.14e-05	0.00252	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTZ1—urinary bladder cancer	1.14e-05	0.00252	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—UGT2B7—urinary bladder cancer	1.12e-05	0.00248	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PRSS3—urinary bladder cancer	1.11e-05	0.00245	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	1.1e-05	0.00243	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTO2—urinary bladder cancer	1.08e-05	0.00239	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NAT1—urinary bladder cancer	1.08e-05	0.00239	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HDAC4—urinary bladder cancer	1.06e-05	0.00234	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	1.04e-05	0.00231	CbGpPWpGaD
Dactinomycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	1.03e-05	0.00228	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CYP4B1—urinary bladder cancer	1.01e-05	0.00223	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—UGT2B7—urinary bladder cancer	9.86e-06	0.00218	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—SLC19A1—urinary bladder cancer	9.53e-06	0.00211	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	9.4e-06	0.00208	CbGpPWpGaD
Dactinomycin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	9.31e-06	0.00206	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PRSS3—urinary bladder cancer	9.29e-06	0.00206	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.16e-06	0.00203	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	9e-06	0.00199	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	8.98e-06	0.00199	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CYP4B1—urinary bladder cancer	8.88e-06	0.00197	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	8.74e-06	0.00193	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	8.58e-06	0.0019	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—LIG1—urinary bladder cancer	8.4e-06	0.00186	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—SLC19A1—urinary bladder cancer	8.38e-06	0.00186	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PRSS3—urinary bladder cancer	8.17e-06	0.00181	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	7.6e-06	0.00168	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.44e-06	0.00165	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—TYMP—urinary bladder cancer	7.42e-06	0.00164	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.33e-06	0.00162	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.13e-06	0.00158	CbGpPWpGaD
Dactinomycin—SLC22A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.74e-06	0.00149	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.72e-06	0.00149	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NAT2—urinary bladder cancer	6.71e-06	0.00149	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.69e-06	0.00148	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.66e-06	0.00147	CbGpPWpGaD
Dactinomycin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	6.54e-06	0.00145	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—TYMP—urinary bladder cancer	6.53e-06	0.00145	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ENO2—urinary bladder cancer	6.41e-06	0.00142	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.15e-06	0.00136	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RBX1—urinary bladder cancer	6.07e-06	0.00134	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NAT2—urinary bladder cancer	5.91e-06	0.00131	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.84e-06	0.00129	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.83e-06	0.00129	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.83e-06	0.00129	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—RRM2—urinary bladder cancer	5.79e-06	0.00128	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.77e-06	0.00128	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—JAG1—urinary bladder cancer	5.44e-06	0.0012	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—HPGDS—urinary bladder cancer	5.37e-06	0.00119	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ENO2—urinary bladder cancer	5.37e-06	0.00119	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.34e-06	0.00118	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	5.33e-06	0.00118	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTT1—urinary bladder cancer	5.21e-06	0.00115	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.13e-06	0.00113	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—RRM2—urinary bladder cancer	5.1e-06	0.00113	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.95e-06	0.0011	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.89e-06	0.00108	CbGpPWpGaD
Dactinomycin—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.87e-06	0.00108	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.8e-06	0.00106	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.78e-06	0.00106	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ENO2—urinary bladder cancer	4.72e-06	0.00105	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—HPGDS—urinary bladder cancer	4.72e-06	0.00105	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTT1—urinary bladder cancer	4.58e-06	0.00101	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.53e-06	0.001	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.42e-06	0.000978	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NQO1—urinary bladder cancer	4.33e-06	0.000958	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.32e-06	0.000956	CbGpPWpGaD
Dactinomycin—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.29e-06	0.000949	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.2e-06	0.000929	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.18e-06	0.000925	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.17e-06	0.000923	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.98e-06	0.00088	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—NCOR1—urinary bladder cancer	3.96e-06	0.000876	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.87e-06	0.000856	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NQO1—urinary bladder cancer	3.81e-06	0.000843	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERCC2—urinary bladder cancer	3.72e-06	0.000824	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.66e-06	0.00081	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTP1—urinary bladder cancer	3.61e-06	0.000799	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.53e-06	0.000782	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MTHFR—urinary bladder cancer	3.5e-06	0.000774	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.49e-06	0.000773	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—TERT—urinary bladder cancer	3.49e-06	0.000772	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.47e-06	0.000767	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.39e-06	0.00075	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—TYMS—urinary bladder cancer	3.35e-06	0.000742	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—NCOR1—urinary bladder cancer	3.32e-06	0.000734	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GSTM1—urinary bladder cancer	3.32e-06	0.000734	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.23e-06	0.000715	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.2e-06	0.000709	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—FGFR3—urinary bladder cancer	3.2e-06	0.000709	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.19e-06	0.000707	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—GPX1—urinary bladder cancer	3.18e-06	0.000703	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTP1—urinary bladder cancer	3.17e-06	0.000703	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—ERCC2—urinary bladder cancer	3.12e-06	0.00069	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—TYMS—urinary bladder cancer	2.95e-06	0.000653	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—MTHFR—urinary bladder cancer	2.93e-06	0.000649	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—NCOR1—urinary bladder cancer	2.92e-06	0.000646	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GSTM1—urinary bladder cancer	2.92e-06	0.000646	CbGpPWpGaD
Dactinomycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.85e-06	0.00063	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—GPX1—urinary bladder cancer	2.79e-06	0.000618	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.76e-06	0.00061	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—ERCC2—urinary bladder cancer	2.74e-06	0.000607	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CREBBP—urinary bladder cancer	2.73e-06	0.000603	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—MTHFR—urinary bladder cancer	2.58e-06	0.000571	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.55e-06	0.000565	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.55e-06	0.000565	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.48e-06	0.000548	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—RHOA—urinary bladder cancer	2.47e-06	0.000546	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PPARG—urinary bladder cancer	2.38e-06	0.000526	CbGpPWpGaD
Dactinomycin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.32e-06	0.000513	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—CREBBP—urinary bladder cancer	2.28e-06	0.000505	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—ERBB2—urinary bladder cancer	2.28e-06	0.000505	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTGS2—urinary bladder cancer	2.23e-06	0.000494	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PPARG—urinary bladder cancer	2.09e-06	0.000463	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.06e-06	0.000456	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—CREBBP—urinary bladder cancer	2.01e-06	0.000445	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.95e-06	0.000432	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—PTEN—urinary bladder cancer	1.95e-06	0.000431	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.87e-06	0.000414	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EP300—urinary bladder cancer	1.86e-06	0.000411	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—SRC—urinary bladder cancer	1.81e-06	0.0004	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.72e-06	0.00038	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.64e-06	0.000364	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—PTEN—urinary bladder cancer	1.63e-06	0.000361	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—MYC—urinary bladder cancer	1.62e-06	0.000358	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.6e-06	0.000353	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—EGFR—urinary bladder cancer	1.58e-06	0.00035	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.58e-06	0.000349	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.58e-06	0.000349	CbGpPWpGaD
Dactinomycin—ABCC1—Metabolism—EP300—urinary bladder cancer	1.55e-06	0.000344	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.51e-06	0.000334	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—KRAS—urinary bladder cancer	1.49e-06	0.000331	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.48e-06	0.000328	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—PTEN—urinary bladder cancer	1.43e-06	0.000318	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.39e-06	0.000309	CbGpPWpGaD
Dactinomycin—ABCG2—Metabolism—EP300—urinary bladder cancer	1.37e-06	0.000303	CbGpPWpGaD
Dactinomycin—ABCC1—Disease—HRAS—urinary bladder cancer	1.27e-06	0.000281	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.13e-06	0.00025	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.09e-06	0.00024	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.89e-07	0.000197	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.76e-07	0.000172	CbGpPWpGaD
Dactinomycin—ABCB1—Metabolism—EP300—urinary bladder cancer	7.4e-07	0.000164	CbGpPWpGaD
